nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Methotrexate—muscle cancer	0.0596	0.396	CbGbCtD
Dipyridamole—ABCB1—Dactinomycin—muscle cancer	0.031	0.206	CbGbCtD
Dipyridamole—PDE8B—larynx—muscle cancer	0.0278	0.0757	CbGeAlD
Dipyridamole—PDE8B—hindlimb—muscle cancer	0.0216	0.0587	CbGeAlD
Dipyridamole—ABCB1—Vincristine—muscle cancer	0.0191	0.127	CbGbCtD
Dipyridamole—PDE8B—appendage—muscle cancer	0.0185	0.0504	CbGeAlD
Dipyridamole—ABCB1—Etoposide—muscle cancer	0.0175	0.116	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—muscle cancer	0.0119	0.0792	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—muscle cancer	0.0116	0.0767	CbGbCtD
Dipyridamole—PDE6A—head—muscle cancer	0.00899	0.0244	CbGeAlD
Dipyridamole—PDE6A—testis—muscle cancer	0.00868	0.0236	CbGeAlD
Dipyridamole—PDE6C—head—muscle cancer	0.00852	0.0232	CbGeAlD
Dipyridamole—PRUNE—cardiac atrium—muscle cancer	0.00761	0.0207	CbGeAlD
Dipyridamole—PDE7A—renal system—muscle cancer	0.00669	0.0182	CbGeAlD
Dipyridamole—PRUNE—tendon—muscle cancer	0.00663	0.018	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vincristine—muscle cancer	0.00648	0.372	CbGdCrCtD
Dipyridamole—PRUNE—Podofilox—Etoposide—muscle cancer	0.00648	0.372	CbGdCrCtD
Dipyridamole—PDE1C—head—muscle cancer	0.0063	0.0171	CbGeAlD
Dipyridamole—PDE6D—bone marrow—muscle cancer	0.0062	0.0169	CbGeAlD
Dipyridamole—PDE1C—testis—muscle cancer	0.00609	0.0166	CbGeAlD
Dipyridamole—PDE6D—vagina—muscle cancer	0.00594	0.0162	CbGeAlD
Dipyridamole—PDE11A—tendon—muscle cancer	0.00586	0.0159	CbGeAlD
Dipyridamole—PDE6B—vagina—muscle cancer	0.00585	0.0159	CbGeAlD
Dipyridamole—PRUNE—testis—muscle cancer	0.00549	0.0149	CbGeAlD
Dipyridamole—PDE6B—head—muscle cancer	0.0054	0.0147	CbGeAlD
Dipyridamole—PDE6D—testis—muscle cancer	0.0053	0.0144	CbGeAlD
Dipyridamole—PDE6B—testis—muscle cancer	0.00522	0.0142	CbGeAlD
Dipyridamole—PDE6H—head—muscle cancer	0.00502	0.0137	CbGeAlD
Dipyridamole—PDE11A—testis—muscle cancer	0.00485	0.0132	CbGeAlD
Dipyridamole—PDE6G—head—muscle cancer	0.00483	0.0131	CbGeAlD
Dipyridamole—PDE6G—testis—muscle cancer	0.00467	0.0127	CbGeAlD
Dipyridamole—PDE7B—tendon—muscle cancer	0.00456	0.0124	CbGeAlD
Dipyridamole—PDE7A—head—muscle cancer	0.00448	0.0122	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vincristine—muscle cancer	0.00446	0.256	CbGdCrCtD
Dipyridamole—PDE2A—cardiac atrium—muscle cancer	0.00437	0.0119	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—muscle cancer	0.00435	0.0118	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—muscle cancer	0.00421	0.0115	CbGeAlD
Dipyridamole—PDE1A—renal system—muscle cancer	0.00405	0.011	CbGeAlD
Dipyridamole—PDE7B—head—muscle cancer	0.00391	0.0106	CbGeAlD
Dipyridamole—PDE10A—tendon—muscle cancer	0.00381	0.0104	CbGeAlD
Dipyridamole—PDE2A—tendon—muscle cancer	0.00381	0.0104	CbGeAlD
Dipyridamole—PDE7B—testis—muscle cancer	0.00378	0.0103	CbGeAlD
Dipyridamole—PDE8A—cardiac atrium—muscle cancer	0.00375	0.0102	CbGeAlD
Dipyridamole—PDE2A—vagina—muscle cancer	0.00353	0.00961	CbGeAlD
Dipyridamole—ADA—renal system—muscle cancer	0.00345	0.00937	CbGeAlD
Dipyridamole—PDE3B—bone marrow—muscle cancer	0.00344	0.00935	CbGeAlD
Dipyridamole—PDE8B—vagina—muscle cancer	0.00337	0.00917	CbGeAlD
Dipyridamole—PDE8A—tendon—muscle cancer	0.00327	0.00889	CbGeAlD
Dipyridamole—PDE2A—head—muscle cancer	0.00326	0.00888	CbGeAlD
Dipyridamole—PDE10A—head—muscle cancer	0.00326	0.00888	CbGeAlD
Dipyridamole—PDE1B—head—muscle cancer	0.00324	0.0088	CbGeAlD
Dipyridamole—PDE1A—tendon—muscle cancer	0.00316	0.0086	CbGeAlD
Dipyridamole—PDE2A—testis—muscle cancer	0.00315	0.00858	CbGeAlD
Dipyridamole—PDE10A—testis—muscle cancer	0.00315	0.00858	CbGeAlD
Dipyridamole—PDE1B—testis—muscle cancer	0.00313	0.0085	CbGeAlD
Dipyridamole—PDE8B—head—muscle cancer	0.00311	0.00847	CbGeAlD
Dipyridamole—PDE8A—vagina—muscle cancer	0.00303	0.00825	CbGeAlD
Dipyridamole—PDE8B—testis—muscle cancer	0.00301	0.00818	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—muscle cancer	0.00297	0.00807	CbGeAlD
Dipyridamole—PDE3B—testis—muscle cancer	0.00294	0.00799	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—muscle cancer	0.00289	0.00785	CbGeAlD
Dipyridamole—PDE5A—renal system—muscle cancer	0.00286	0.00777	CbGeAlD
Dipyridamole—PDE1A—head—muscle cancer	0.00271	0.00737	CbGeAlD
Dipyridamole—PDE8A—testis—muscle cancer	0.00271	0.00736	CbGeAlD
Dipyridamole—ADA—tendon—muscle cancer	0.00269	0.00732	CbGeAlD
Dipyridamole—PDE1A—testis—muscle cancer	0.00262	0.00712	CbGeAlD
Dipyridamole—ADA—bone marrow—muscle cancer	0.00261	0.00709	CbGeAlD
Dipyridamole—ADA—vagina—muscle cancer	0.0025	0.00679	CbGeAlD
Dipyridamole—PDE3A—cardiac atrium—muscle cancer	0.00249	0.00677	CbGeAlD
Dipyridamole—SLC29A1—renal system—muscle cancer	0.0024	0.00652	CbGeAlD
Dipyridamole—ABCC5—cardiac atrium—muscle cancer	0.00234	0.00636	CbGeAlD
Dipyridamole—ADA—head—muscle cancer	0.00231	0.00627	CbGeAlD
Dipyridamole—PDE5A—tendon—muscle cancer	0.00223	0.00606	CbGeAlD
Dipyridamole—ADA—testis—muscle cancer	0.00223	0.00606	CbGeAlD
Dipyridamole—PDE4A—testis—muscle cancer	0.00217	0.0059	CbGeAlD
Dipyridamole—PDE3A—tendon—muscle cancer	0.00217	0.0059	CbGeAlD
Dipyridamole—SLC29A1—cardiac atrium—muscle cancer	0.00215	0.00584	CbGeAlD
Dipyridamole—PDE5A—vagina—muscle cancer	0.00207	0.00563	CbGeAlD
Dipyridamole—ABCC5—tendon—muscle cancer	0.00204	0.00554	CbGeAlD
Dipyridamole—ABCC5—bone marrow—muscle cancer	0.00197	0.00537	CbGeAlD
Dipyridamole—PDE5A—head—muscle cancer	0.00191	0.0052	CbGeAlD
Dipyridamole—ABCC5—vagina—muscle cancer	0.00189	0.00514	CbGeAlD
Dipyridamole—SLC29A1—tendon—muscle cancer	0.00187	0.00509	CbGeAlD
Dipyridamole—PDE5A—testis—muscle cancer	0.00185	0.00502	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—muscle cancer	0.00181	0.00493	CbGeAlD
Dipyridamole—ABCC4—renal system—muscle cancer	0.00181	0.00492	CbGeAlD
Dipyridamole—PDE3A—testis—muscle cancer	0.0018	0.00488	CbGeAlD
Dipyridamole—SLC29A1—vagina—muscle cancer	0.00174	0.00472	CbGeAlD
Dipyridamole—ABCC5—testis—muscle cancer	0.00169	0.00459	CbGeAlD
Dipyridamole—SLC29A1—head—muscle cancer	0.0016	0.00436	CbGeAlD
Dipyridamole—SLC29A1—testis—muscle cancer	0.00155	0.00421	CbGeAlD
Dipyridamole—ABCC4—tendon—muscle cancer	0.00141	0.00384	CbGeAlD
Dipyridamole—ABCC4—bone marrow—muscle cancer	0.00137	0.00372	CbGeAlD
Dipyridamole—ABCC4—head—muscle cancer	0.00121	0.00329	CbGeAlD
Dipyridamole—ABCC4—testis—muscle cancer	0.00117	0.00318	CbGeAlD
Dipyridamole—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00103	0.0052	CcSEcCtD
Dipyridamole—Bone disorder—Doxorubicin—muscle cancer	0.00103	0.0052	CcSEcCtD
Dipyridamole—Angiopathy—Vincristine—muscle cancer	0.00101	0.00509	CcSEcCtD
Dipyridamole—Ill-defined disorder—Dactinomycin—muscle cancer	0.00101	0.00507	CcSEcCtD
Dipyridamole—Mediastinal disorder—Vincristine—muscle cancer	0.00101	0.00506	CcSEcCtD
Dipyridamole—Anaemia—Dactinomycin—muscle cancer	0.001	0.00505	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Etoposide—muscle cancer	0.000992	0.00499	CcSEcCtD
Dipyridamole—Myocardial infarction—Etoposide—muscle cancer	0.000986	0.00496	CcSEcCtD
Dipyridamole—Alopecia—Vincristine—muscle cancer	0.000986	0.00496	CcSEcCtD
Dipyridamole—Malaise—Dactinomycin—muscle cancer	0.00098	0.00493	CcSEcCtD
Dipyridamole—Atrioventricular block—Doxorubicin—muscle cancer	0.000962	0.00484	CcSEcCtD
Dipyridamole—Pulmonary oedema—Methotrexate—muscle cancer	0.000959	0.00482	CcSEcCtD
Dipyridamole—Coordination abnormal—Doxorubicin—muscle cancer	0.00095	0.00478	CcSEcCtD
Dipyridamole—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000944	0.00475	CcSEcCtD
Dipyridamole—Back pain—Vincristine—muscle cancer	0.000939	0.00472	CcSEcCtD
Dipyridamole—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000933	0.00469	CcSEcCtD
Dipyridamole—Injection site reaction—Doxorubicin—muscle cancer	0.000928	0.00467	CcSEcCtD
Dipyridamole—Myalgia—Dactinomycin—muscle cancer	0.000925	0.00465	CcSEcCtD
Dipyridamole—Eructation—Doxorubicin—muscle cancer	0.000917	0.00461	CcSEcCtD
Dipyridamole—Discomfort—Dactinomycin—muscle cancer	0.000914	0.0046	CcSEcCtD
Dipyridamole—Hypoaesthesia—Etoposide—muscle cancer	0.000899	0.00452	CcSEcCtD
Dipyridamole—Anaemia—Vincristine—muscle cancer	0.000897	0.00451	CcSEcCtD
Dipyridamole—Oedema—Dactinomycin—muscle cancer	0.000887	0.00446	CcSEcCtD
Dipyridamole—Vertigo—Vincristine—muscle cancer	0.000872	0.00439	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dactinomycin—muscle cancer	0.000868	0.00437	CcSEcCtD
Dipyridamole—Convulsion—Vincristine—muscle cancer	0.000841	0.00423	CcSEcCtD
Dipyridamole—Flushing—Etoposide—muscle cancer	0.000838	0.00422	CcSEcCtD
Dipyridamole—Cardiac disorder—Etoposide—muscle cancer	0.000838	0.00422	CcSEcCtD
Dipyridamole—Hypertension—Vincristine—muscle cancer	0.000838	0.00422	CcSEcCtD
Dipyridamole—ABCB1—embryo—muscle cancer	0.000832	0.00226	CbGeAlD
Dipyridamole—Pulmonary oedema—Doxorubicin—muscle cancer	0.000831	0.00418	CcSEcCtD
Dipyridamole—Myalgia—Vincristine—muscle cancer	0.000827	0.00416	CcSEcCtD
Dipyridamole—Angiopathy—Etoposide—muscle cancer	0.00082	0.00412	CcSEcCtD
Dipyridamole—Hypertonia—Doxorubicin—muscle cancer	0.000818	0.00411	CcSEcCtD
Dipyridamole—Immune system disorder—Etoposide—muscle cancer	0.000816	0.0041	CcSEcCtD
Dipyridamole—Mediastinal disorder—Etoposide—muscle cancer	0.000814	0.0041	CcSEcCtD
Dipyridamole—Chills—Etoposide—muscle cancer	0.000811	0.00408	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000808	0.00407	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000808	0.00406	CcSEcCtD
Dipyridamole—Alopecia—Etoposide—muscle cancer	0.000798	0.00402	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Methotrexate—muscle cancer	0.000798	0.00402	CcSEcCtD
Dipyridamole—Anaphylactic shock—Vincristine—muscle cancer	0.000792	0.00399	CcSEcCtD
Dipyridamole—Oedema—Vincristine—muscle cancer	0.000792	0.00399	CcSEcCtD
Dipyridamole—Nervous system disorder—Vincristine—muscle cancer	0.000777	0.00391	CcSEcCtD
Dipyridamole—Thrombocytopenia—Vincristine—muscle cancer	0.000776	0.0039	CcSEcCtD
Dipyridamole—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000775	0.0039	CcSEcCtD
Dipyridamole—Dysgeusia—Etoposide—muscle cancer	0.00077	0.00387	CcSEcCtD
Dipyridamole—Hyperhidrosis—Vincristine—muscle cancer	0.000766	0.00385	CcSEcCtD
Dipyridamole—Fatigue—Dactinomycin—muscle cancer	0.000765	0.00385	CcSEcCtD
Dipyridamole—Back pain—Etoposide—muscle cancer	0.000761	0.00383	CcSEcCtD
Dipyridamole—Pain—Dactinomycin—muscle cancer	0.000758	0.00381	CcSEcCtD
Dipyridamole—Muscle spasms—Etoposide—muscle cancer	0.000756	0.0038	CcSEcCtD
Dipyridamole—Eye pain—Doxorubicin—muscle cancer	0.00075	0.00377	CcSEcCtD
Dipyridamole—Hypotension—Vincristine—muscle cancer	0.00074	0.00372	CcSEcCtD
Dipyridamole—Feeling abnormal—Dactinomycin—muscle cancer	0.000731	0.00368	CcSEcCtD
Dipyridamole—Ill-defined disorder—Etoposide—muscle cancer	0.00073	0.00367	CcSEcCtD
Dipyridamole—Anaemia—Etoposide—muscle cancer	0.000727	0.00366	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000725	0.00365	CcSEcCtD
Dipyridamole—Hot flush—Doxorubicin—muscle cancer	0.000724	0.00364	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000722	0.00363	CcSEcCtD
Dipyridamole—Increased appetite—Doxorubicin—muscle cancer	0.000721	0.00363	CcSEcCtD
Dipyridamole—Menopausal symptoms—Doxorubicin—muscle cancer	0.000718	0.00361	CcSEcCtD
Dipyridamole—Paraesthesia—Vincristine—muscle cancer	0.000711	0.00358	CcSEcCtD
Dipyridamole—Malaise—Etoposide—muscle cancer	0.000709	0.00357	CcSEcCtD
Dipyridamole—Vertigo—Etoposide—muscle cancer	0.000707	0.00355	CcSEcCtD
Dipyridamole—Abdominal pain—Dactinomycin—muscle cancer	0.000701	0.00353	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.0007	0.00352	CcSEcCtD
Dipyridamole—Loss of consciousness—Etoposide—muscle cancer	0.000691	0.00348	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000691	0.00348	CcSEcCtD
Dipyridamole—Cough—Etoposide—muscle cancer	0.000686	0.00345	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Vincristine—muscle cancer	0.000684	0.00344	CcSEcCtD
Dipyridamole—Fatigue—Vincristine—muscle cancer	0.000683	0.00344	CcSEcCtD
Dipyridamole—Convulsion—Etoposide—muscle cancer	0.000681	0.00343	CcSEcCtD
Dipyridamole—Hypertension—Etoposide—muscle cancer	0.000679	0.00342	CcSEcCtD
Dipyridamole—Pain—Vincristine—muscle cancer	0.000678	0.00341	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000677	0.00341	CcSEcCtD
Dipyridamole—Chest pain—Etoposide—muscle cancer	0.00067	0.00337	CcSEcCtD
Dipyridamole—Migraine—Doxorubicin—muscle cancer	0.000667	0.00335	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000665	0.00334	CcSEcCtD
Dipyridamole—Discomfort—Etoposide—muscle cancer	0.000662	0.00333	CcSEcCtD
Dipyridamole—Hypersensitivity—Dactinomycin—muscle cancer	0.000653	0.00329	CcSEcCtD
Dipyridamole—Abdominal discomfort—Methotrexate—muscle cancer	0.000648	0.00326	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Vincristine—muscle cancer	0.000648	0.00326	CcSEcCtD
Dipyridamole—Cardiac arrest—Doxorubicin—muscle cancer	0.000644	0.00324	CcSEcCtD
Dipyridamole—Anaphylactic shock—Etoposide—muscle cancer	0.000642	0.00323	CcSEcCtD
Dipyridamole—Asthenia—Dactinomycin—muscle cancer	0.000636	0.0032	CcSEcCtD
Dipyridamole—ABCB1—renal system—muscle cancer	0.00063	0.00171	CbGeAlD
Dipyridamole—Thrombocytopenia—Etoposide—muscle cancer	0.000628	0.00316	CcSEcCtD
Dipyridamole—Tachycardia—Etoposide—muscle cancer	0.000626	0.00315	CcSEcCtD
Dipyridamole—Abdominal pain—Vincristine—muscle cancer	0.000626	0.00315	CcSEcCtD
Dipyridamole—Skin disorder—Etoposide—muscle cancer	0.000623	0.00314	CcSEcCtD
Dipyridamole—Hyperhidrosis—Etoposide—muscle cancer	0.000621	0.00312	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000619	0.00311	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000619	0.00311	CcSEcCtD
Dipyridamole—Diarrhoea—Dactinomycin—muscle cancer	0.000607	0.00305	CcSEcCtD
Dipyridamole—Hypotension—Etoposide—muscle cancer	0.0006	0.00302	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—muscle cancer	0.000585	0.00294	CcSEcCtD
Dipyridamole—Hypersensitivity—Vincristine—muscle cancer	0.000584	0.00294	CcSEcCtD
Dipyridamole—Paraesthesia—Etoposide—muscle cancer	0.000576	0.0029	CcSEcCtD
Dipyridamole—Dyspnoea—Etoposide—muscle cancer	0.000572	0.00288	CcSEcCtD
Dipyridamole—Somnolence—Etoposide—muscle cancer	0.000571	0.00287	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—muscle cancer	0.00057	0.00287	CcSEcCtD
Dipyridamole—Asthenia—Vincristine—muscle cancer	0.000568	0.00286	CcSEcCtD
Dipyridamole—Vomiting—Dactinomycin—muscle cancer	0.000564	0.00284	CcSEcCtD
Dipyridamole—Rash—Dactinomycin—muscle cancer	0.000559	0.00281	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000554	0.00279	CcSEcCtD
Dipyridamole—Fatigue—Etoposide—muscle cancer	0.000553	0.00278	CcSEcCtD
Dipyridamole—Pain—Etoposide—muscle cancer	0.000549	0.00276	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—muscle cancer	0.000544	0.00274	CcSEcCtD
Dipyridamole—Diarrhoea—Vincristine—muscle cancer	0.000542	0.00273	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—muscle cancer	0.000541	0.00272	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—muscle cancer	0.000541	0.00272	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—muscle cancer	0.000537	0.0027	CcSEcCtD
Dipyridamole—Feeling abnormal—Etoposide—muscle cancer	0.000529	0.00266	CcSEcCtD
Dipyridamole—Nausea—Dactinomycin—muscle cancer	0.000527	0.00265	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Etoposide—muscle cancer	0.000525	0.00264	CcSEcCtD
Dipyridamole—Dizziness—Vincristine—muscle cancer	0.000524	0.00264	CcSEcCtD
Dipyridamole—Urticaria—Etoposide—muscle cancer	0.00051	0.00256	CcSEcCtD
Dipyridamole—Abdominal pain—Etoposide—muscle cancer	0.000507	0.00255	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—muscle cancer	0.000505	0.00254	CcSEcCtD
Dipyridamole—Vomiting—Vincristine—muscle cancer	0.000504	0.00253	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—muscle cancer	0.000502	0.00253	CcSEcCtD
Dipyridamole—Rash—Vincristine—muscle cancer	0.0005	0.00251	CcSEcCtD
Dipyridamole—Dermatitis—Vincristine—muscle cancer	0.000499	0.00251	CcSEcCtD
Dipyridamole—Headache—Vincristine—muscle cancer	0.000496	0.0025	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—muscle cancer	0.000491	0.00247	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—muscle cancer	0.000489	0.00246	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—muscle cancer	0.000488	0.00245	CcSEcCtD
Dipyridamole—Chills—Methotrexate—muscle cancer	0.000486	0.00244	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—muscle cancer	0.000478	0.00241	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—muscle cancer	0.000477	0.0024	CcSEcCtD
Dipyridamole—ABCB1—bone marrow—muscle cancer	0.000476	0.0013	CbGeAlD
Dipyridamole—Hypersensitivity—Etoposide—muscle cancer	0.000473	0.00238	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—muscle cancer	0.000471	0.00237	CcSEcCtD
Dipyridamole—Nausea—Vincristine—muscle cancer	0.000471	0.00237	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—muscle cancer	0.00047	0.00236	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—muscle cancer	0.000469	0.00236	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—muscle cancer	0.000469	0.00236	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000466	0.00235	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—muscle cancer	0.000465	0.00234	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—muscle cancer	0.000461	0.00232	CcSEcCtD
Dipyridamole—Asthenia—Etoposide—muscle cancer	0.000461	0.00232	CcSEcCtD
Dipyridamole—ABCB1—vagina—muscle cancer	0.000456	0.00124	CbGeAlD
Dipyridamole—Back pain—Methotrexate—muscle cancer	0.000456	0.00229	CcSEcCtD
Dipyridamole—Pruritus—Etoposide—muscle cancer	0.000454	0.00228	CcSEcCtD
Dipyridamole—Diarrhoea—Etoposide—muscle cancer	0.000439	0.00221	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—muscle cancer	0.000437	0.0022	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—muscle cancer	0.000437	0.0022	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—muscle cancer	0.000435	0.00219	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—muscle cancer	0.000435	0.00219	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—muscle cancer	0.000435	0.00219	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—muscle cancer	0.000425	0.00214	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—muscle cancer	0.000425	0.00214	CcSEcCtD
Dipyridamole—Dizziness—Etoposide—muscle cancer	0.000424	0.00214	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—muscle cancer	0.000423	0.00213	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—muscle cancer	0.000423	0.00213	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000422	0.00212	CcSEcCtD
Dipyridamole—ABCB1—head—muscle cancer	0.000422	0.00115	CbGeAlD
Dipyridamole—Chills—Doxorubicin—muscle cancer	0.00042	0.00211	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—muscle cancer	0.000419	0.00211	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—muscle cancer	0.000414	0.00208	CcSEcCtD
Dipyridamole—Cough—Methotrexate—muscle cancer	0.000411	0.00207	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—muscle cancer	0.000408	0.00205	CcSEcCtD
Dipyridamole—Vomiting—Etoposide—muscle cancer	0.000408	0.00205	CcSEcCtD
Dipyridamole—ABCB1—testis—muscle cancer	0.000407	0.00111	CbGeAlD
Dipyridamole—Rash—Etoposide—muscle cancer	0.000405	0.00204	CcSEcCtD
Dipyridamole—Dermatitis—Etoposide—muscle cancer	0.000404	0.00203	CcSEcCtD
Dipyridamole—Headache—Etoposide—muscle cancer	0.000402	0.00202	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—muscle cancer	0.000402	0.00202	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—muscle cancer	0.000401	0.00202	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—muscle cancer	0.000401	0.00202	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—muscle cancer	0.000401	0.00202	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—muscle cancer	0.0004	0.00201	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—muscle cancer	0.000399	0.00201	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000398	0.002	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—muscle cancer	0.000396	0.00199	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—muscle cancer	0.000396	0.00199	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—muscle cancer	0.000395	0.00198	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—muscle cancer	0.000392	0.00197	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—muscle cancer	0.000384	0.00193	CcSEcCtD
Dipyridamole—Nausea—Etoposide—muscle cancer	0.000381	0.00192	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000378	0.0019	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—muscle cancer	0.000377	0.0019	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—muscle cancer	0.000377	0.0019	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—muscle cancer	0.000376	0.00189	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—muscle cancer	0.000373	0.00188	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—muscle cancer	0.000372	0.00187	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—muscle cancer	0.000368	0.00185	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—muscle cancer	0.000366	0.00184	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—muscle cancer	0.000366	0.00184	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—muscle cancer	0.00036	0.00181	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—muscle cancer	0.000359	0.00181	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—muscle cancer	0.000359	0.0018	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—muscle cancer	0.000356	0.00179	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—muscle cancer	0.000353	0.00178	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—muscle cancer	0.000352	0.00177	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00035	0.00176	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—muscle cancer	0.000347	0.00175	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—muscle cancer	0.000347	0.00175	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—muscle cancer	0.000347	0.00175	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—muscle cancer	0.000346	0.00174	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—muscle cancer	0.000345	0.00174	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000345	0.00173	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—muscle cancer	0.000343	0.00173	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—muscle cancer	0.000343	0.00172	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—muscle cancer	0.000342	0.00172	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—muscle cancer	0.00034	0.00171	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—muscle cancer	0.000338	0.0017	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000333	0.00167	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—muscle cancer	0.000333	0.00167	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000332	0.00167	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—muscle cancer	0.000331	0.00167	CcSEcCtD
Dipyridamole—Pain—Methotrexate—muscle cancer	0.000329	0.00165	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—muscle cancer	0.000328	0.00165	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—muscle cancer	0.000326	0.00164	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000326	0.00164	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—muscle cancer	0.000325	0.00163	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—muscle cancer	0.000323	0.00163	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000322	0.00162	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—muscle cancer	0.000317	0.00159	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000314	0.00158	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—muscle cancer	0.000311	0.00156	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—muscle cancer	0.000305	0.00154	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—muscle cancer	0.000304	0.00153	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000303	0.00153	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—muscle cancer	0.000299	0.0015	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—muscle cancer	0.000297	0.00149	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—muscle cancer	0.000296	0.00149	CcSEcCtD
Dipyridamole—PDE1B—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000295	0.00111	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—FOXO4—muscle cancer	0.000294	0.00111	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—FOXO4—muscle cancer	0.000294	0.00111	CbGpPWpGaD
Dipyridamole—Dyspepsia—Doxorubicin—muscle cancer	0.000293	0.00147	CcSEcCtD
Dipyridamole—PDE1B—Innate Immune System—FOXO4—muscle cancer	0.000292	0.0011	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00029	0.00109	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CNR1—muscle cancer	0.000288	0.00109	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CNR1—muscle cancer	0.000288	0.00109	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—KIT—muscle cancer	0.000288	0.00108	CbGpPWpGaD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000287	0.00145	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—muscle cancer	0.000287	0.00144	CcSEcCtD
Dipyridamole—PDE2A—Signaling Pathways—FOXO4—muscle cancer	0.000286	0.00108	CbGpPWpGaD
Dipyridamole—Pain—Doxorubicin—muscle cancer	0.000285	0.00143	CcSEcCtD
Dipyridamole—PDE1A—Hemostasis—IGF2—muscle cancer	0.000284	0.00107	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—VEGFA—muscle cancer	0.000284	0.00107	CbGpPWpGaD
Dipyridamole—Hypersensitivity—Methotrexate—muscle cancer	0.000283	0.00142	CcSEcCtD
Dipyridamole—PDE11A—Signaling Pathways—PTCH1—muscle cancer	0.000283	0.00107	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PTCH1—muscle cancer	0.000283	0.00107	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CNR1—muscle cancer	0.000281	0.00106	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—KIT—muscle cancer	0.000277	0.00105	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—KIT—muscle cancer	0.000277	0.00105	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IGF2—muscle cancer	0.000277	0.00104	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IGF2—muscle cancer	0.000277	0.00104	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PTCH1—muscle cancer	0.000276	0.00104	CbGpPWpGaD
Dipyridamole—Asthenia—Methotrexate—muscle cancer	0.000276	0.00139	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—muscle cancer	0.000274	0.00138	CcSEcCtD
Dipyridamole—PDE1A—Immune System—CD34—muscle cancer	0.000273	0.00103	CbGpPWpGaD
Dipyridamole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000272	0.00137	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—muscle cancer	0.000272	0.00137	CcSEcCtD
Dipyridamole—ADA—Metabolism—MED12—muscle cancer	0.000266	0.001	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—MDM2—muscle cancer	0.000265	0.001	CbGpPWpGaD
Dipyridamole—Urticaria—Doxorubicin—muscle cancer	0.000264	0.00133	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—muscle cancer	0.000263	0.00132	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—muscle cancer	0.000263	0.00132	CcSEcCtD
Dipyridamole—PDE1C—Signaling Pathways—PTCH1—muscle cancer	0.000262	0.000988	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—FOXO4—muscle cancer	0.000262	0.000986	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—IGF2—muscle cancer	0.00026	0.00098	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—TP53—muscle cancer	0.00026	0.000978	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PTCH1—muscle cancer	0.000259	0.000975	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PTCH1—muscle cancer	0.000259	0.000974	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—FOXO1—muscle cancer	0.000258	0.00097	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CNR1—muscle cancer	0.000257	0.000967	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CNR1—muscle cancer	0.000257	0.000967	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—FOXO1—muscle cancer	0.000255	0.00096	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—FOXO1—muscle cancer	0.000255	0.00096	CbGpPWpGaD
Dipyridamole—Dizziness—Methotrexate—muscle cancer	0.000254	0.00128	CcSEcCtD
Dipyridamole—PDE10A—Signaling Pathways—PTCH1—muscle cancer	0.000252	0.00095	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PTCH1—muscle cancer	0.000252	0.000947	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD34—muscle cancer	0.00025	0.000942	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—MDM2—muscle cancer	0.000248	0.000934	CbGpPWpGaD
Dipyridamole—Hypersensitivity—Doxorubicin—muscle cancer	0.000245	0.00123	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—muscle cancer	0.000244	0.00123	CcSEcCtD
Dipyridamole—PDE11A—Signaling Pathways—FOXO4—muscle cancer	0.000243	0.000916	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—FOXO4—muscle cancer	0.000243	0.000916	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ENO2—muscle cancer	0.000243	0.000914	CbGpPWpGaD
Dipyridamole—Rash—Methotrexate—muscle cancer	0.000242	0.00122	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—muscle cancer	0.000242	0.00122	CcSEcCtD
Dipyridamole—PDE11A—Hemostasis—VEGFA—muscle cancer	0.000242	0.00091	CbGpPWpGaD
Dipyridamole—Headache—Methotrexate—muscle cancer	0.000241	0.00121	CcSEcCtD
Dipyridamole—PDE4A—GPCR downstream signaling—CNR1—muscle cancer	0.00024	0.000905	CbGpPWpGaD
Dipyridamole—Asthenia—Doxorubicin—muscle cancer	0.000239	0.0012	CcSEcCtD
Dipyridamole—PDE11A—Signaling Pathways—CNR1—muscle cancer	0.000239	0.000899	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CNR1—muscle cancer	0.000239	0.000899	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—FOXO1—muscle cancer	0.000238	0.000896	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PTCH1—muscle cancer	0.000237	0.000891	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—FOXO1—muscle cancer	0.000236	0.000888	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IGF2—muscle cancer	0.000236	0.000887	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IGF2—muscle cancer	0.000236	0.000887	CbGpPWpGaD
Dipyridamole—Pruritus—Doxorubicin—muscle cancer	0.000236	0.00118	CcSEcCtD
Dipyridamole—PDE6G—Disease—FOXO1—muscle cancer	0.000235	0.000884	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CNR1—muscle cancer	0.000234	0.000881	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CNR1—muscle cancer	0.000233	0.000878	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IGF2—muscle cancer	0.00023	0.000865	CbGpPWpGaD
Dipyridamole—Nausea—Methotrexate—muscle cancer	0.000228	0.00115	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—muscle cancer	0.000228	0.00115	CcSEcCtD
Dipyridamole—PDE1B—Signaling by NGF—MDM2—muscle cancer	0.000227	0.000854	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—FOXO4—muscle cancer	0.000226	0.000849	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—FOXO4—muscle cancer	0.000223	0.000838	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CNR1—muscle cancer	0.000221	0.000834	CbGpPWpGaD
Dipyridamole—Dizziness—Doxorubicin—muscle cancer	0.00022	0.00111	CcSEcCtD
Dipyridamole—PDE1A—GPCR downstream signaling—CNR1—muscle cancer	0.00022	0.000828	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—MDM2—muscle cancer	0.000219	0.000823	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—MDM2—muscle cancer	0.000219	0.000823	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CNR1—muscle cancer	0.000218	0.000823	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CNR1—muscle cancer	0.000218	0.000822	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—FOXO1—muscle cancer	0.000217	0.000817	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—FOXO4—muscle cancer	0.000217	0.000817	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—FOXO1—muscle cancer	0.000217	0.000817	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PTCH1—muscle cancer	0.000216	0.000815	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—FOXO1—muscle cancer	0.000216	0.000812	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—VEGFA—muscle cancer	0.000215	0.000811	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—VEGFA—muscle cancer	0.000215	0.000811	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—TP53—muscle cancer	0.000215	0.000808	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CNR1—muscle cancer	0.000213	0.000802	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000212	0.0008	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CNR1—muscle cancer	0.000212	0.0008	CbGpPWpGaD
Dipyridamole—Vomiting—Doxorubicin—muscle cancer	0.000212	0.00106	CcSEcCtD
Dipyridamole—PDE2A—Signaling Pathways—FOXO1—muscle cancer	0.000211	0.000796	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—PTGS2—muscle cancer	0.000211	0.000793	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—PTGS2—muscle cancer	0.000211	0.000793	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ENO2—muscle cancer	0.00021	0.000793	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ENO2—muscle cancer	0.00021	0.000793	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IGF2—muscle cancer	0.00021	0.000791	CbGpPWpGaD
Dipyridamole—Rash—Doxorubicin—muscle cancer	0.00021	0.00106	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—muscle cancer	0.00021	0.00105	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—muscle cancer	0.000209	0.00105	CcSEcCtD
Dipyridamole—PDE1B—GPCR downstream signaling—CNR1—muscle cancer	0.000201	0.000757	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CNR1—muscle cancer	0.0002	0.000752	CbGpPWpGaD
Dipyridamole—Nausea—Doxorubicin—muscle cancer	0.000198	0.000995	CcSEcCtD
Dipyridamole—ABCC4—Hemostasis—IGF2—muscle cancer	0.000197	0.000742	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—KIT—muscle cancer	0.000196	0.000739	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IGF2—muscle cancer	0.000195	0.000735	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IGF2—muscle cancer	0.000195	0.000735	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—KIT—muscle cancer	0.000194	0.000732	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—KIT—muscle cancer	0.000194	0.000732	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—MED12—muscle cancer	0.000193	0.000728	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—FOXO1—muscle cancer	0.000193	0.000728	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ENO2—muscle cancer	0.000193	0.000725	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HMGA1—muscle cancer	0.000191	0.00072	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HMGA1—muscle cancer	0.000191	0.00072	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—FOXO4—muscle cancer	0.000186	0.0007	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CNR1—muscle cancer	0.000183	0.000688	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—TP53—muscle cancer	0.000182	0.000687	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—KIT—muscle cancer	0.000181	0.000683	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IGF2—muscle cancer	0.000181	0.000682	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—FOXO1—muscle cancer	0.00018	0.000677	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—FOXO1—muscle cancer	0.00018	0.000677	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—KIT—muscle cancer	0.00018	0.000676	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—KIT—muscle cancer	0.000179	0.000673	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IGF2—muscle cancer	0.000179	0.000673	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ENO2—muscle cancer	0.000176	0.000664	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HMGA1—muscle cancer	0.000175	0.000659	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IGF2—muscle cancer	0.000174	0.000655	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—FOXO4—muscle cancer	0.000172	0.000646	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—FOXO4—muscle cancer	0.000172	0.000646	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—FOXO4—muscle cancer	0.00017	0.00064	CbGpPWpGaD
Dipyridamole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	0.000167	0.00063	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—FOXO1—muscle cancer	0.000167	0.000627	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—KIT—muscle cancer	0.000165	0.000622	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—KIT—muscle cancer	0.000165	0.000622	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—FOXO1—muscle cancer	0.000164	0.000619	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—KIT—muscle cancer	0.000164	0.000619	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTCH1—muscle cancer	0.000163	0.000615	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—muscle cancer	0.000163	0.000613	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—muscle cancer	0.000163	0.000613	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—KIT—muscle cancer	0.000161	0.000606	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00016	0.000604	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—FOXO1—muscle cancer	0.00016	0.000603	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—FOXO4—muscle cancer	0.000157	0.000591	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—MDM2—muscle cancer	0.000155	0.000582	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MDM2—muscle cancer	0.000153	0.000576	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MDM2—muscle cancer	0.000153	0.000576	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTCH1—muscle cancer	0.000153	0.000575	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTCH1—muscle cancer	0.000149	0.00056	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KIT—muscle cancer	0.000147	0.000555	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—VEGFA—muscle cancer	0.000145	0.000545	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MDM2—muscle cancer	0.000143	0.000538	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—MDM2—muscle cancer	0.000141	0.000533	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MDM2—muscle cancer	0.000141	0.00053	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FOXO4—muscle cancer	0.00014	0.000528	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTCH1—muscle cancer	0.00014	0.000526	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—VEGFA—muscle cancer	0.000139	0.000525	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CNR1—muscle cancer	0.000138	0.000519	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PTGS2—muscle cancer	0.000138	0.000518	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—FOXO1—muscle cancer	0.000137	0.000517	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KIT—muscle cancer	0.000137	0.000516	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KIT—muscle cancer	0.000137	0.000516	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PTGS2—muscle cancer	0.000136	0.000511	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FOXO4—muscle cancer	0.000131	0.000495	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MDM2—muscle cancer	0.00013	0.00049	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MDM2—muscle cancer	0.00013	0.00049	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—MDM2—muscle cancer	0.000129	0.000487	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CNR1—muscle cancer	0.000129	0.000486	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FOXO4—muscle cancer	0.000128	0.000481	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTCH1—muscle cancer	0.000128	0.000481	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KIT—muscle cancer	0.000127	0.000478	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—VEGFA—muscle cancer	0.000127	0.000478	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MDM2—muscle cancer	0.000127	0.000478	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—FOXO1—muscle cancer	0.000127	0.000477	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—FOXO1—muscle cancer	0.000127	0.000477	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—FOXO1—muscle cancer	0.000126	0.000473	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CNR1—muscle cancer	0.000125	0.000472	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KIT—muscle cancer	0.000125	0.000472	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KIT—muscle cancer	0.000122	0.00046	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FOXO4—muscle cancer	0.00012	0.000453	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—VEGFA—muscle cancer	0.000119	0.000449	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CNR1—muscle cancer	0.000118	0.000444	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—VEGFA—muscle cancer	0.000116	0.000438	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—VEGFA—muscle cancer	0.000116	0.000438	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MDM2—muscle cancer	0.000116	0.000437	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—FOXO1—muscle cancer	0.000116	0.000437	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF2—muscle cancer	0.000113	0.000424	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FOXO4—muscle cancer	0.00011	0.000414	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—VEGFA—muscle cancer	0.000109	0.000411	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CNR1—muscle cancer	0.000108	0.000406	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MDM2—muscle cancer	0.000108	0.000406	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MDM2—muscle cancer	0.000108	0.000406	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF2—muscle cancer	0.000105	0.000397	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—muscle cancer	0.000105	0.000396	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KIT—muscle cancer	0.000105	0.000394	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FOXO1—muscle cancer	0.000104	0.00039	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF2—muscle cancer	0.000103	0.000386	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MDM2—muscle cancer	0.0001	0.000376	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—VEGFA—muscle cancer	9.88e-05	0.000372	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—VEGFA—muscle cancer	9.88e-05	0.000372	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MDM2—muscle cancer	9.86e-05	0.000371	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FOXO1—muscle cancer	9.7e-05	0.000365	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KIT—muscle cancer	9.66e-05	0.000364	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KIT—muscle cancer	9.66e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF2—muscle cancer	9.64e-05	0.000363	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—VEGFA—muscle cancer	9.63e-05	0.000363	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MDM2—muscle cancer	9.61e-05	0.000362	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—muscle cancer	9.59e-05	0.000361	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KIT—muscle cancer	9.57e-05	0.00036	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FOXO1—muscle cancer	9.44e-05	0.000355	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	9.41e-05	0.000354	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FH—muscle cancer	9.4e-05	0.000354	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	9.07e-05	0.000342	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—muscle cancer	9.01e-05	0.000339	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FOXO1—muscle cancer	8.87e-05	0.000334	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KIT—muscle cancer	8.83e-05	0.000333	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF2—muscle cancer	8.82e-05	0.000332	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—muscle cancer	8.81e-05	0.000332	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—muscle cancer	8.78e-05	0.000331	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—muscle cancer	8.78e-05	0.000331	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—muscle cancer	8.45e-05	0.000318	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—muscle cancer	8.27e-05	0.000311	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—muscle cancer	8.24e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MDM2—muscle cancer	8.24e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—muscle cancer	8.19e-05	0.000308	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—muscle cancer	8.19e-05	0.000308	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FOXO1—muscle cancer	8.12e-05	0.000306	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KIT—muscle cancer	7.9e-05	0.000297	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MDM2—muscle cancer	7.6e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MDM2—muscle cancer	7.6e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—muscle cancer	7.59e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MDM2—muscle cancer	7.53e-05	0.000284	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—muscle cancer	7.49e-05	0.000282	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—muscle cancer	7.47e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—muscle cancer	7.47e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KIT—muscle cancer	7.39e-05	0.000278	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—muscle cancer	7.33e-05	0.000276	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—muscle cancer	7.33e-05	0.000276	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—muscle cancer	7.3e-05	0.000275	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—muscle cancer	7.28e-05	0.000274	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KIT—muscle cancer	7.19e-05	0.000271	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.15e-05	0.000269	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MDM2—muscle cancer	6.96e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KIT—muscle cancer	6.76e-05	0.000255	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—muscle cancer	6.7e-05	0.000253	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—muscle cancer	6.65e-05	0.000251	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—muscle cancer	6.25e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MDM2—muscle cancer	6.22e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—muscle cancer	6.19e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—muscle cancer	6.19e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KIT—muscle cancer	6.18e-05	0.000233	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—muscle cancer	6.14e-05	0.000231	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MDM2—muscle cancer	5.82e-05	0.000219	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—muscle cancer	5.74e-05	0.000216	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MDM2—muscle cancer	5.66e-05	0.000213	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—muscle cancer	5.66e-05	0.000213	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—muscle cancer	5.51e-05	0.000208	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.4e-05	0.000203	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—muscle cancer	5.33e-05	0.000201	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MED12—muscle cancer	5.31e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—muscle cancer	4.87e-05	0.000183	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO2—muscle cancer	4.84e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—muscle cancer	4.72e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—muscle cancer	4.42e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—muscle cancer	4.3e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—muscle cancer	4.04e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—muscle cancer	3.7e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—muscle cancer	3.57e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—muscle cancer	3.34e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—muscle cancer	3.25e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—muscle cancer	3.06e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—muscle cancer	2.79e-05	0.000105	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—muscle cancer	1.69e-05	6.35e-05	CbGpPWpGaD
